Modulation of the serum inflammatory response in thrombolytic patients by acupuncture via olink proteomic analysis for the treatment of stroke: a randomized controlled trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400087156

Enrollment

Unknown

Registered

2024-07-22

Start date

2024-08-01

Completion date

Unknown

Last updated

2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

acupuncture group:acupuncture

sham acupuncture group :sham acupuncture

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. the patient meets the clinical diagnostic criteria of ischemic stroke and is treated with thrombolysis; 2. patients can cooperate with treatment and observation, are conscious and have stable vital signs; 3. The age is between 18 and 80 years old; 4. The patient accepts the treatment of this program, is informed and signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1. those with serious complications or infections prior to admission; 2. those with visual or auditory impairments who are unable to match the survey assessment; 3. women during pregnancy or lactation; 4. patients participating in other clinical trials within 1 month; 5. those with a previous history of psychiatric disorders.

Design outcomes

Primary

Measure	Time frame
national institute of health stroke scale;	—

Secondary

Measure	Time frame
Fugl-Meyer;Homocysteine;olink proteomic;	—

Countries

China

Contacts

Public ContactYanlin Liu

Jiaxing Hospital of Traditional Chinese Medicine

liuyanlin2193@163.com+86 189 4510 4116

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026